Specific Tolerance Induction and Organ Transplantation

References

• Billingham R.E., Brent L., Medawar P.B. “Actively acquired tolerance” of foreign cells. Nature 1953; 172: 603
   PubMed Web of Science ®Google Scholar
• Opelz G., Sengar D.P.S., Mickey M.R., Terasaki P.I. Effect of blood transfusions on subsequent kidney transplants. Transplantproc 1973; 5: 253
   PubMed Web of Science ®Google Scholar
• Lagaaij E.L., Hennemann I.P.H., Ruigrok M., de Haan M.W., Persijn G.G., Termijtelen A., Hendriks G.F.J., Weimar W., Claas F.H.J., van Rood J.J. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701
   PubMed Web of Science ®Google Scholar
• van Twuyver E., Mooijaart R.J.D., ten Berge R.J.M., van der Horst A.R., Wilmink J.M., Kast W.M., Melief C.J.M., de Waal L.P. Pretransplant blood transfusion revisited. N Engl J Med 1991; 325: 1210
   PubMed Web of Science ®Google Scholar
• Roelen D.L., Dover E.L., Niimi M., Young N.T., Morris P.J., Wood K.J. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness. Eur J Immunol 1996; 26: 1468
   PubMed Web of Science ®Google Scholar
• van Rood J.J., Claas F.H.J. The influence of allogeneic cells on the human T and B-cell repertoire. Science 1990; 248: 1388
   PubMed Web of Science ®Google Scholar
• de Waal L.P., van Twuyver E. Blood transfusion and allograft survival. Crit Rev Immunol 1991; 10: 417
   PubMed Web of Science ®Google Scholar
• Opelz G., Vanrenterghem Y., Kirste G., et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997; 63: 964
   PubMed Web of Science ®Google Scholar
• Sharabi Y., Sachs D.H. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989; 169: 493
   PubMed Web of Science ®Google Scholar
• Qin S., Cobbold S., Benjamin R., Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169: 179
   Web of Science ®Google Scholar
• Mayumi H., Good R.A. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med 1989; 169: 213
   PubMed Web of Science ®Google Scholar
• Leong L.Y.W., Qin S., Cobbold S.P., Waldmann H. Classical transplantation tolerance in the adult: the interaction between myeloablation and immunsuppression. Eur J Immunol 1992; 22: 2825
   PubMed Web of Science ®Google Scholar
• de Vries-van der Zwan A., Besseling A.C., Kievits F., van Twuyver E., de Waal L.P. Anti-CD3 treatment facilitates engraftment of full H-2 disparate donor bone marrow cells and subsequent skin allograft tolerance. Transplantation 1994; 58: 610
   PubMed Web of Science ®Google Scholar
• Kawai T., Cosimi A.B., Colvin R.B., Powelson J., Eason J., Kozlowski T., Sykes M., Monroy R., Tanaka M., Sachs D.H. Mixed allogeneic chimerism and renal allograft tolerance in cynolmolgus monkeys. Transplantation 1995; 59: 256
   PubMed Web of Science ®Google Scholar
• Colson Y.L., Zadach K., Nalesnik M., Ildstad S.T. Mixed allogeneic chimerism in the rat. Transplantation 1995; 60: 971
   PubMed Web of Science ®Google Scholar
• Sykes M., Szot G.L., Swenson K.A., Pearson D.A. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosup-pressive conditioning. Nature Med 1997; 3: 783
   PubMed Web of Science ®Google Scholar
• Colson Y.L., Wren S.M., Schuchert M.J., Patrene K.D., Johnson P.C., Boggs S.S., Ildstad S.T. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol 1995; 155: 4179
   PubMed Web of Science ®Google Scholar
• Posselt A.M., Barker C.F., Tomaszewski J.E., Markmann J.F., Choti M.A., Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990; 249: 1293
   PubMed Web of Science ®Google Scholar
• Naji A. Induction of tolerance by intrathymic inoculation of alloantigen. Curr Opin Immunol 1996; 8: 704
   PubMed Web of Science ®Google Scholar
• Oluwole S.F., Chowdhury N.C., Jin M.X., Hardy M.A. Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides. Transplantation 1993; 56: 1523
   PubMed Web of Science ®Google Scholar
• Sayegh M.H., Perico N., Gallon L., Imberti O., Hancock W.W., Remuzzi G., Carpenter C.B. Mechanisms of acquired thymic unresponsiveness to renal allografts. Transplantation 1994; 58: 125
   PubMed Web of Science ®Google Scholar
• Sayegh M.H., Zhang Z.J., Hancock W.W., Kwok C.A., Carpenter C.B., Weiner H.L. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation 1992; 53: 163
   PubMed Web of Science ®Google Scholar
• Madsen J.C., Superina R.A., Wood K.J., Morris P.J. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161
   PubMed Web of Science ®Google Scholar
• Sykes M., Sachs D.H., Nienhuis A.W., Pearson D.A., Moulton A.D., Bodine D.M. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 1993; 55: 197
   PubMed Web of Science ®Google Scholar
• Saitovitch D., Morris P.J., Wood K.J. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Transplantation 1996; 61: 1532
   PubMed Web of Science ®Google Scholar
• Qin L., Chavin K.D., Ding Y., Favaro J.P., Woodward J.E., Lin J., Tahara H., Robbins P., Shaked A., Ho D.Y., Sapolsky R.M., Lotze M.T., Bromberg J.S. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Transplantation 1995; 59: 809
   PubMed Web of Science ®Google Scholar
• Knechtle S.J. Gene therapy and transplantation-A brief review. Transplant Proc 1996; 28(No 6, Suppl 1)19
   PubMed Web of Science ®Google Scholar
• Lau H.T., Yu M., Fontana A., Stoeckert C.J., Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273: 109
   PubMed Web of Science ®Google Scholar
• Ellenhorn J.D.I., Hirsch R., Schreiber H., Bluestone J.A. In vivo administration of anti-CD3 prevents malignant progressor tumor growth. Science 1988; 242: 569
   PubMed Web of Science ®Google Scholar
• Hirsch R., Eckhaus M., Auchincloss H., Jr., Sachs D.H., Bluestone J.A. Effects of in vivo administration of anti-T3 monoclonal antibody on T-cell function in mice: I Immunosuppression of transplantation responses. J Immunol 1988; 140: 3766
   PubMed Web of Science ®Google Scholar
• Hirsch R., Gress R.E., Pluznik D.H., Eckhaus M., Bluestone J.A. Effects of in vivo administration of anti-CD3 monoclonal antibody on T-cell function in mice. II. In vivo activation of T-cells. J Immunol 1989; 142: 737
   PubMed Web of Science ®Google Scholar
• Hiruma K., Hirsch R., Patchen M., Bluestone J.A., Gress R.E. Effects of anti-CD3 monoclonal antibody on engraftment of T-cell-depleted bone marrow allografts in mice: Host T-cell suppression, growth factors, and space. Blood 1992; 79: 3050
   PubMed Web of Science ®Google Scholar
• Ferran C., Sheehan K., Dy M., Schreiber R., Merite S., Landais P., Noel L.H., Grau G., Bluestone J.A., Bach J.F., Chatenoud L. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody. Further evidence for transient in vivo T-cell activation. Eur J Immunol 1990; 20: 509
   PubMed Web of Science ®Google Scholar
• Chen Z., Cobbold S., Metcalfe S., Waldmann H. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 1992; 22: 805
   PubMed Web of Science ®Google Scholar
• de Vries-van der Zwan A., Besseling A.C., van Twuyver E., Boog C.J.P., de Waal L.P. A substantial level of mixed chimerism is required for the induction of permanent transplantation tolerance. Transplant Immunol 1996; 4: 227
   PubMedGoogle Scholar
• de Vries-van der Zwan A., Besseling A.C., de Waal L.P., Boog C.J.P. Specific tolerance induction and transplantation: a single day protocol. Blood 1997; 89: 2596
   PubMed Web of Science ®Google Scholar
• de Vries-van der Zwan A., van der Pol M.A., Besseling A.C., de Waal L.P., Boog C.J.P. Stem cell transfusion as a new method for the induction of tolerance in organ transplantation. Transplant Proc 1997; 29: 1209
   PubMed Web of Science ®Google Scholar
• Tomita Y., Khan A., Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1997; 153: 1087–39
   Google Scholar
• Orloff S.L., Hirose R., Lin Z., Narumi S., Stock P.G., Ascher N.L. Clonal deletion is one mechanism responsible for tolerance in mixed hematopoietic chimeras. Transplant Proc 1994; 29: 1198
   Web of Science ®Google Scholar
• Colson Y.L., Lange J., Fowler K., Ildstad S.T. Mechanism for cotolerance in nonlethally conditioned mixed chimeras: negative selection of the Vp T-cell receptor repertoire by both host and donor bone marrow-derived cells. Blood 1996; 88: 4601
   PubMed Web of Science ®Google Scholar
• Qin S., Wise M., Cobbold S.P., Leong L., Kong Y.C.M., Pames J.R., Waldmann H. Induction of tolerance in peripheral T-cells with monoclonal antibodies. Eur J Immunol 1990; 20: 2737
   PubMed Web of Science ®Google Scholar
• Ramsdell F., Lantz T., Fowlkes B.J. A nondele-tional mechanism of thymic self tolerance. Science 1989; 246: 1038
   PubMed Web of Science ®Google Scholar
• Qin S., Cobbold S.P., Pope H., Elliott J., Kioussis D., Davis J., Waldmann H. “Infectious” transplantation tolerance. Science 1993; 259: 974
   PubMed Web of Science ®Google Scholar
• Murphy D.B. T cell mediated immunosuppression. Curr Opin Immunol 1993; 5: 411
   PubMed Web of Science ®Google Scholar
• Alard P., Levy R., Kosiewicz M., Jones M., Streilein J.W. MHC class II tolerant T cells undergo apoptosis upon re-exposure to tolerogen in vivo. Transplant Immunol 1996; 4: 76
   PubMedGoogle Scholar
• Charlton B., Auchincloss H., Jr., Fathman C.G. Mechanisms of transplantation tolerance. Annu Rev Immunol 1994; 12: 707
   PubMed Web of Science ®Google Scholar
• Starzl T.E., Demetris A.J., Murase N., Ildstad S.T., Ricordi C., Trucco M. Cell migration, chimerism and graft acceptance. Lancet 1992; 339: 1579
   PubMed Web of Science ®Google Scholar
• Starzl T.E., Demetris A.J., Trucco M., Ramos H., Zeevi A., Rudert W.A., Kocova M., Ricordi C., Ildstad S.T., Murase N. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876
   Google Scholar
• Starzl T.E., Demetris A.J., Trucco M., Zeevi A., Ramos H., Terasaki P., Rudert W.A., Kocova M., Ricordi C., Ildstad S.T., Murase N. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272
   PubMedGoogle Scholar
• Suberbielle C., Caillat-Zucman S., Legendre C., Bodemer C., Noel L.H., Kreis H., Bach J.F. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet 1994; 343: 1468
   PubMed Web of Science ®Google Scholar
• Schlitt H.J., Hundrieser J., Ringe B., Pichlmayr R., Hon F. R. C. S. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 1994; 330: 646
   Google Scholar
• Schlitt H.J., Hundrieser J., Hisanaga M., Uthoff K., Karck M., Wahlers T., Wonigeit K., Pichlmayr R. Patters of donor-type microchimerism after heart transplantation. Lancet 1994; 343: 1469
   PubMed Web of Science ®Google Scholar
• Elwood E.T., Larsen C.P., Maurer D.H., Routenberg K.L., Neylan J.F., Whelchel J.D., O'Brien D.P., Pearson T.C. Microchimerism and rejection in clinical transplantation. Lazier 1997; 349: 1358
   Google Scholar
• Fontes P., Rao A.S., Demetris A.J., Zeevi A., Trucco M., Carroll P., Rybka W., Rudert W.A., Ricordi C., Dodson F., Shapiro R., Tzakis A., Todo S., Abu-Elmagd K., Jordan M., Fung J.J., Starzl T.E. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151
   PubMed Web of Science ®Google Scholar
• Garcia-Morales R., Carreno M., Mathew J., Zucker K., Cirocco R., Ciancio G., Burke G., Roth D., Temple D., Rosen A., Fuller L., Esquenazi V., Karatzas T., Ricordi TzalisC., Miller J. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest 1997; 99: 1118
   PubMed Web of Science ®Google Scholar
• Shapiro R., Rao A.S., Fontes P., Jordan M., Scantlebury BV.P., Vivas C., Demetris A.J., Zeevi A., Rybka W., Carroll P., Trucco M., Starzl T.E. Combined kidney/bone marrow transplantation: evidence of augmentation of chimerism. Transplantation 1995; 59: 306
   PubMed Web of Science ®Google Scholar